| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應商 |
| 325-89-3 | 3-氨基-3-(4-氟苯基)丙酸 | 3-Amino-3-(4-fluorophenyl)propanoic acid; Hydrocinnamicacid, b-amino-p-fluoro- (6CI,8CI); 3-Amino-3-(4-fluorophenyl)propionic acid | ![]() | C9H10FNO2 | 詳情 | 供應商 |
| 1847-24-1 | 氟氯西林鈉; (2S,5R,6R)-6-[[3-(2-氯-6-氟苯基)-5-甲基-1,2-惡唑-4-甲酰]氨基]-3,3-二甲基-7-氧代-4-硫雜-1- | Flucloxacillin sodium; Sodium (2S,5R,6R)-6-[[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate | ![]() | C19H16ClFN3NaO5S | 詳情 | 供應商 |
| 4116-02-3 | N-芐基-1-(4-氟苯基)-2-甲基-2-氨基丙烷 | N-Benzyl-1-(4-fluorophenyl)-2-methyl-2-aminopropane; N-Benzyl-1,1-dimethyl-2-(4-fluorophenyl)ethylamine | ![]() | C17H20FN | 詳情 | 供應商 |
| 5250-39-5 | 氟氯西林; (2S,5R,6R)-6-[[3-(2-氯-6-氟苯基)-5-甲基-1,2-惡唑-4-甲酰]氨基]-3,3-二甲基-7-氧代-4-硫雜-1-氮 | Flucloxacillin; (2S,5R,6R)-6-[[3-(2-Chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | ![]() | C19H17ClFN3O5S | 詳情 | 供應商 |
| 56995-20-1 | 氟吡汀; 氟必定; 氟必汀; N-[2-氨基-6-[(4-氟苯基)甲基氨基]吡啶-3-基]氨基甲酸乙酯 | Flupirtine; Ethyl N-[2-amino-6-[(4-fluorophenyl)methylamino]pyridin-3-yl]carbamate | ![]() | C15H17FN4O2 | 詳情 | 供應商 |
| 59729-32-7 | 氫溴酸西酞普蘭; 1-[3-(二甲氨基)丙基]-1-(4-氟苯基)-1,3-二氫-5-異苯并呋喃甲腈氫溴酸鹽 | Citalopram hydrobromide; 1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile hydrobromide | ![]() | C20H21FN2O.HBr;C20H22BrFN2O | 詳情 | 供應商 |
| 59729-33-8 | 西酞普蘭; 1-[3-(二甲氨基)丙基]-1-(4-氟苯基)-1,3-二氫-5-異苯并呋喃甲腈 | Citalopram; 1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile | ![]() | C20H21FN2O | 詳情 | 供應商 |
| 84501-68-8 | 4-[[1-[(4-氟苯基)甲基]-1H-苯并咪唑-2-基]氨基]哌啶-1-甲酸乙酯 | Ethyl 4-[[1-[(4-fluorophenyl)methyl]-1H-benzimidazol-2-yl]amino]piperidine-1-carboxylate | ![]() | C22H25FN4O2 | 詳情 | 供應商 |
| 85118-27-0 | 鹽酸西酞普蘭; 1-[3-(二甲氨基)丙基]-1-(4-氟苯基)-1,3-二氫-5-異苯并呋喃甲腈鹽酸鹽 | Citalopram hydrochloride; 1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile hydrochloride | ![]() | C20H22ClFN2O | 詳情 | 供應商 |
| 103146-26-5 | 4-[4-(二甲氨基)-1-(4-氟苯基)-1-羥丁基]-3-羥甲基苯腈氫溴酸鹽 | 4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile hydrobromide | ![]() | C20H24BrFN2O2 | 詳情 | 供應商 |
| 107097-79-0 | 甲苯磺酸妥舒沙星; 7-(3-氨基吡咯烷-1-基)-1-(2,4-二氟苯基)-6-氟-1,4-二氫-4-氧-1,8-萘啶-3-羧酸對甲苯磺酸 | Tosufloxacin tosilate; 7-(3-Aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid 4-methylbenzenesulfonate hydrate | ![]() | C26H25F3N4O7S | 詳情 | 供應商 |
| 108138-46-1 | 托氟沙星; 7-(3-氨基吡咯烷-1-基)-1-(2,4-二氟苯基)-6-氟-4-氧代-1,8-萘啶-3-羧酸 | Tosufloxacin; 7-(3-Aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid | ![]() | C19H15F3N4O3 | 詳情 | 供應商 |
| 108612-45-9 | 咪唑司汀; 2-[[1-[1-[(4-氟苯基)甲基]苯并咪唑-2-基]-4-哌啶基]-甲基氨基]-3H-嘧啶-4-酮 | Mizolastine; 2-[[1-[1-[(4-Fluorophenyl)methyl]benzoimidazol-2-yl]-4-piperidyl]-methyl-amino]-3H-pyrimidin-4-one | ![]() | C24H25FN6O | 詳情 | 供應商 |
| 110862-48-1 | 阿伐他汀; 阿托伐他汀; (3S,5S)-7-[2-(4-氟苯基)-3-苯基-4-(苯基氨基甲;)-5-異丙基吡咯-1-基]-3,5-二羥基? | Atorvastatin; (3S,5S)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid | ![]() | C33H35FN2O5 | 詳情 | 供應商 |
| 115964-29-9 | 甲苯磺酸妥舒沙星; 甲苯磺酸托氟沙星; 7-(3-氨基吡咯烷-1-基)-1-(2,4-二氟苯基)-6-氟-4-氧代-1,8-萘啶-3-甲酸 | Tosufloxacin tosylate; 7-(3-Aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid 4-methylbenzenesulfonate | ![]() | C26H23F3N4O6S | 詳情 | 供應商 |
| 117391-51-2 | 3-氨基-3-(3-氟苯基)丙酸 | 3-Amino-3-(3-fluorophenyl)propanoic acid; 3-Fluorophenyl-beta-DL-alanine | ![]() | C9H10FNO2 | 詳情 | 供應商 |
| 125995-03-1 | 阿托伐他汀內(nèi)酯; (4R,6R)-6-{2-[2-(4-氟苯基)-5-異丙基-3-苯基-4-(苯基氨基甲;)吡咯-1-基]乙基}-4-羥基四 | Atorvastatin lactone; (4R,6R)-6-{2-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]ethyl}-4-hydroxytetrahydro-2H-pyran-2-one | ![]() | C33H33FN2O4 | 詳情 | 供應商 |
| 128173-53-5 | D-DTTA鹽; (-)-4-[4-二甲氨基-1-(4-氟苯基)-1-羥基丁基]-3-羥甲基苯腈D-(+)-二對甲苯甲酰酒石酸鹽(2:1) | (-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-; (S)-4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile (2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]butanedioate (2:1) | ![]() | C60H64F2N4O12 | 詳情 | 供應商 |
| 128196-01-0 | 依他普侖; 1-(3-二甲基氨基丙基)-1-(4-氟苯基)-1,3-二氫異苯并呋喃-5-甲腈 | Escitalopram; 1-(3-Dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile | ![]() | C20H21FN2O | 詳情 | 供應商 |
| 130579-75-8 | 依利色林; (Z,E)-1-(2-氟苯基)-3-(4-羥基苯基)-2-丙烯-1-酮O-[2-(二甲基氨基)乙基]肟 | Eplivanserin; (Z,E)-1-(2-Fluorophenyl)-3-(4-hydroxyphenyl)-2-propen-1-one O-[2-(dimethylamino)ethyl]oxime | ![]() | C19H21FN2O2 | 詳情 | 供應商 |